Intelligence provider Clarivate has released the 12th annual Drugs to Watch report, a guide to the therapies poised to ...
Sanofi reports positive Phase III results for a subcutaneous version of Sarclisa in relapsed or refractory multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback